¿Garantizan las leyes nacionales de control de drogas la disponibilidad de opioides para fines médicos y científicos?

Este informe analiza si las leyes nacionales de control de drogas aseguran la disponibilidad de opioides para fines médicos y científicos.

Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

In a report to the United Nations, the International Narcotics Control Board (INCB) stated:

One of the fundamental objectives of the international drug control treaties is to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes and to promote the rational use of narcotic drugs and psychotropic substances.

Countries that signed the 1961 Single Convention on Narcotic Drugs as Amended by the 1972 Protocol, hereafter referred to as the Single Convention, are expected to abide by the Convention’s provisions on the control of certain drugs while ensuring that these drugs are available for medical purposes. The Single Convention established a medicolegal principle of balance: governments have a dual obligation to prevent the diversion and abuse of narcotic drugs and to ensure adequate provision of opioid analgesics for legitimate medical and scientific purposes.

In this paper, we use the word “balance” in the way it is used by international organizations, such as the United Nations Economic and Social Council, the INCB, the World Health Organization (WHO) and the Commission on Narcotic Drugs.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.